These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 16465788)
1. [Disseminated lupus erythematosis: current therapies and future hopes]. Houssiau FA Bull Mem Acad R Med Belg; 2005; 160(5-6):329-35. PubMed ID: 16465788 [TBL] [Abstract][Full Text] [Related]
2. The application of plasmapheresis in systemic lupus erythematosus. Jones JV Prog Clin Biol Res; 1982; 106():81-9. PubMed ID: 6817336 [No Abstract] [Full Text] [Related]
4. [Disseminated lupus erythematosus; analysis of 100 cases treated with adrenal corticoids & comparison with 25 untreated cases]. JALIL J; ARMAS CRUZ R; HARNECKER J; GONZALEZ F Rev Med Chil; 1958 Dec; 86(12):717-32. PubMed ID: 13624278 [No Abstract] [Full Text] [Related]
5. [Azathioprine in the treatment of disseminated lupus erythematosus]. Bokemeyer B; Thiele KG MMW Munch Med Wochenschr; 1982 May; 124(19):475-7. PubMed ID: 6810112 [No Abstract] [Full Text] [Related]
6. Systemic lupus erythematosus in children: current and emerging therapies. Macdermott EJ; Adams A; Lehman TJ Lupus; 2007; 16(8):677-83. PubMed ID: 17711907 [TBL] [Abstract][Full Text] [Related]
7. [Management of systemic lupus erythematosus (LED) and related diseases]. Munthe E Tidsskr Nor Laegeforen; 1973 Mar; 93(8):533-6. PubMed ID: 4697597 [No Abstract] [Full Text] [Related]
8. [Therapy and prognosis of collagen diseases (mainly of systemic lupus erythematosus), with special reference to the results of follow-up study at the special outpatient clinic]. Shibata S; Nagasawa T; Naruse T; Miyakawa Y; Kitamura K Naika; 1970; 25(5):882-7. PubMed ID: 5421842 [No Abstract] [Full Text] [Related]
9. [Lupus erythematosus. 5. Current status and trends in therapy of lupus erythematosus: a) S.L.E.: therapy with antimalarials, steroid therapy and monitoring, acupuncture; b) D.L.E.; c) Therapy of oral lesions and xerostomia; d) Dental treatment during L.E]. Frojo M; Palomba F; Rullo R Arch Stomatol (Napoli); 1989 Nov; 30(5):1113-25. PubMed ID: 2641870 [No Abstract] [Full Text] [Related]
16. Criteria for steroid-sparing ability of interventions in systemic lupus erythematosus: report of a consensus meeting. Ad Hoc Working Group on Steroid-Sparing Criteria in Lupus Arthritis Rheum; 2004 Nov; 50(11):3427-31. PubMed ID: 15529380 [No Abstract] [Full Text] [Related]
18. [Fundamentals and problems of lupus erythematosus therapy]. Randow U; Sönnichsen N; Weidauer S Z Gesamte Inn Med; 1968 Sep; 23(17):513-9. PubMed ID: 4882481 [No Abstract] [Full Text] [Related]
19. [Observations on changes in the leukocyte pattern and methodical studies of the LE cell phenomenon in disseminated lupus erythematodes]. Hoigné R; Bütikofer E; Vögeli H Schweiz Med Wochenschr; 1966 Sep; 96(37):1229-32. PubMed ID: 4171965 [No Abstract] [Full Text] [Related]
20. General considerations in the treatment of systemic lupus erythematosus. Rothfield NF Mayo Clin Proc; 1969 Sep; 44(9):691-6. PubMed ID: 5821139 [No Abstract] [Full Text] [Related] [Next] [New Search]